Literature DB >> 22653581

A common genetic variant of 5p15.33 is associated with risk for prostate cancer in the Chinese population.

Q Ren1, B Xu, S Q Chen, Y Yang, C Y Wang, Y D Wang, X H Wang, L X Hua, M Chen.   

Abstract

Recent evidence has suggested that single-nucleotide polymorphisms (SNPs) located at 5p15.33 contribute to susceptibilities for several cancer types, including prostate cancer. To determine whether SNP rs402710 in this region plays a role in prostate cancer, we analyzed these associations in a Chinese population; 251 prostate cancer patients and 273 control subjects were included in this case-control study. Genotypes were determined by PCR-RFLP. We found that subjects carrying the CC homozygote had a decreased risk for prostrate cancer compared to those carrying TT/TC genotypes (odds ratio (OR) = 0.69, 95% confidence interval (CI) = 0.48-0.98, P = 0.038). Compared with the TT homozygote, subjects carrying the CC homozygote also had a decreased risk for prostate cancer (OR = 0.71, 95%CI = 0.51-0.99, P = 0.043). We conclude that rs402710 polymorphisms in the 5p15.33 region are associated with prostate cancer risk in the Chinese population. Further investigations with large cohorts and done worldwide are warranted to determine whether our findings are detected in other populations.

Entities:  

Mesh:

Year:  2012        PMID: 22653581     DOI: 10.4238/2012.May.15.5

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  1 in total

1.  CLPTM1L gene rs402710 (C > T) and rs401681 (C > T) polymorphisms associate with decreased cancer risk: a meta-analysis.

Authors:  Jianzhou Tang; Changming Hu; Hua Mei; Liang Peng; Hui Li
Journal:  Oncotarget       Date:  2017-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.